New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab
Credit: Unsplash/CC0 Public Domain More-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic leukemia (T-ALL). St. Jude Children’s Research Hospital scientists have leveraged …